Jeffrey P. Ward - Concepedia

Author

Jeffrey P. Ward

Washington University in St. Louis ORCID

Also Known As

J Ward, J. P. Ward, J. Ward, J.P. Ward, Jeffery P. Ward, Jeffrey P Ward, Jeffrey P. Ward, Jeffrey Ward

140

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis Rush University Medical Center SUNY Upstate Medical University James S. McDonnell Foundation Jewish Hospital

About

Jeffrey P. Ward is an author at Washington University in St. Louis specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	2.8K
2	Cell Biology	6	6	1.3K
3	Health Sciences	1	1	90
4	Natural Sciences	1	1	10
5	Biomolecular Engineering	1	1	10

Jeffrey P. Ward

Publications

Citations

H-Index

Page 1

	Year	Citations
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens Matthew M. Gubin, Xiuli Zhang, Heiko Schuster, Nature	2014	2K
MHC-II neoantigens shape tumour immunity and response to immunotherapy Elise Alspach, Danielle M. Lussier, Alexander P. Miceli, Nature Tumor ImmunologyCancer ImmunosurveillanceMhc-ii NeoantigensImmunologyTumor Immunity	2019	837
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity Stephen T. Ferris, Vivek Durai, Renee Wu, Nature Tumor ImmunologyCancer ImmunosurveillanceT-regulatory CellImmunologyTumor Immunity	2020	537
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang, Cell Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2020	507
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy Matthew M. Gubin, Ekaterina Esaulova, Jeffrey P. Ward, Cell Tumor BiologyLymphoid NeoplasiaMedicineMalignant Blood DisorderImmunology	2018	407
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape Takuro Noguchi, Jeffrey P. Ward, Matthew M. Gubin, Cancer Immunology Research	2017	316
Degranulation of Natural Killer Cells Following Interaction with HIV-1-Infected Cells Is Hindered by Downmodulation of NTB-A by Vpu Ankur H. Shah, Bharatwaj Sowrirajan, Zachary Davis, Cell Host & Microbe Human RetrovirusImmunologyAntiviral ResponseChronic Viral InfectionHiv	2010	187
HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts Jeffrey P. Ward, Matthew Bonaparte, Jennifer Sacks, Blood	2007	185
HIV-1 Vpr Triggers Natural Killer Cell–Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response Jeffrey P. Ward, Zachary Davis, Jason L. DeHart, PLoS Pathogens	2009	137
Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads Danielle M. Lussier, Elise Alspach, Jeffrey P. Ward, Proceedings of the National Academy of Sciences	2021	123

Page 1